Ofev (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Ofev drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | nintedanib |
| SUBSTANCE NAME: | NINTEDANIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-10-15 |
| END MARKETING DATE: | 0000-00-00 |
Ofev HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ofev from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2014-10-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0143_48fb6088-dc4d-01f5-ce27-bdf6e30ed5a9 |
| PRODUCT NDC: | 0597-0143 |
| APPLICATION NUMBER: | NDA205832 |
Other NINTEDANIB Pharmaceutical Manufacturers / Labelers:
